BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- +10 vs. Q3 2025
- Shares held
- 57.9M
- +1.08M (+1.9%) vs. Q3 2025
- Total value
- $724.7M
- +$67.2M (+10.2%) vs. Q3 2025
- New holders
- 14
- 12 more added
- Sold out
- 4
- 12 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 17,878,594 | $223.8M | 12.69% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 4,885,446 | $61.2M | 0.78% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 3,289,661 | $41.2M | 14.37% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,907,003 | $36.4M | 0.01% | −54,260−1.8% | Reduced |
| EcoR1 Capital, LLC | 2,823,126 | $35.3M | 1.62% | 00.0% | Unchanged |
| Alphabet Inc. | 2,823,126 | $35.3M | 1.37% | 00.0% | Unchanged |
| Enavate Sciences GP, LLC | 2,626,946 | $32.9M | 6.49% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,530,324 | $31.7M | 0.02% | −7,817−0.3% | Reduced |
| Paradigm Biocapital Advisors LP | 2,261,749 | $28.3M | 0.76% | +395,608+21.2% | Added |
| BlackRock, Inc. | 2,084,837 | $26.1M | 0.00% | +36,285+1.8% | Added |
| Novo Holdings A/S | 1,961,317 | $24.6M | 1.91% | 00.0% | Unchanged |
| Laurion Capital Management LP | 1,464,938 | $18.3M | 1.25% | +419,138+40.1% | Added |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $17.5M | 0.03% | −87,621−5.9% | Reduced |
| Eventide Asset Management, LLC | 1,082,362 | $13.4M | 0.21% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,043,110 | $13.1M | 1.63% | 00.0% | Unchanged |
| Armistice Capital, LLC | 1,000,000 | $12.5M | 0.31% | +588,000+142.7% | Added |
| Price T Rowe Associates Inc | 803,134 | $10.1M | 0.00% | −81,908−9.3% | Reduced |
| Vanguard Group Inc | 791,095 | $9.90M | 0.00% | +143,496+22.2% | Added |
| Aisling Capital Management LP | 564,625 | $7.07M | 1.48% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 561,987 | $7.04M | 0.00% | +20,385+3.8% | Added |
| Casdin Capital, LLC | 282,312 | $3.53M | 0.22% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 279,046 | $3.49M | 0.00% | −304−0.1% | Reduced |
| Millennium Management LLC | 241,415 | $3.02M | 0.00% | −128,148−34.7% | Reduced |
| FMR LLC | 240,300 | $3.01M | 0.00% | +78,223+48.3% | Added |
| HighVista Strategies LLC | 229,263 | $2.87M | 0.74% | +229,263 | New |
| ADAR1 Capital Management, LLC | 226,248 | $2.83M | 0.21% | −274,980−54.9% | Reduced |
| Ikarian Capital, LLC | 220,231 | $2.76M | 0.36% | −25,000−10.2% | Reduced |
| State Street Corp | 218,278 | $2.73M | 0.00% | +41,583+23.5% | Added |
| Sio Capital Management, LLC | 130,628 | $1.64M | 0.27% | 00.0% | Unchanged |
| TD Asset Management Inc | 117,150 | $1.47M | 0.00% | −12,912−9.9% | Reduced |
| Woodline Partners LP | 103,707 | $1.30M | 0.01% | 00.0% | Unchanged |
| Moore Capital Management, LP | 100,000 | $1.25M | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 94,651 | $1.19M | 0.00% | +94,651 | New |
| UBS Group AG | 93,369 | $1.17M | 0.00% | +41,143+78.8% | Added |
| StemPoint Capital LP | 86,517 | $1.08M | 0.19% | −100,097−53.6% | Reduced |
| Renaissance Technologies LLC | 74,300 | $930.2K | 0.00% | +74,300 | New |
| Boothbay Fund Management, LLC | 67,034 | $839.3K | 0.02% | −29,517−30.6% | Reduced |
| Northern Trust Corp | 58,034 | $726.6K | 0.00% | −37,923−39.5% | Reduced |
| Manufacturers Life Insurance Company, The | 54,192 | $670.4K | 0.00% | +54,192 | New |
| Qube Research & Technologies Ltd | 35,952 | $450.1K | 0.00% | +35,952 | New |
| XTX Topco Ltd | 28,633 | $358.5K | 0.01% | +5,249+22.4% | Added |
| BNP Paribas Arbitrage, SA | 26,472 | $331.4K | 0.00% | +26,472 | New |
| BIT Capital GmbH | 25,000 | $313.0K | 0.01% | +25,000 | New |
| Point72 Asset Management, L.P. | 23,584 | $295.3K | 0.00% | +23,584 | New |
| Morgan Stanley | 14,352 | $179.7K | 0.00% | +13,491+1,566.9% | Added |
| Quadrature Capital Ltd | 12,922 | $161.8K | 0.00% | +12,922 | New |
| Squarepoint Ops LLC | 11,515 | $144.2K | 0.00% | +11,515 | New |
| Persistent Asset Partners Ltd | 8,585 | $107.5K | 0.05% | +8,585 | New |
| CIBC Private Wealth Group, LLC | 5,000 | $62.6K | 0.00% | +5,000 | New |
| Bank of America Corp | 3,990 | $50.0K | 0.00% | +2,661+200.2% | Added |
| Rockefeller Capital Management L.P. | 700 | $8.76K | 0.00% | +700 | New |
| Wells Fargo & Company | 300 | $3.76K | 0.00% | +300 | New |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −457,414−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −16−100.0% | Sold out |